Burjor Langdana: Why Does Blast Traumatised Facial Tissue Keep Swelling and often Heal Badly
Burjor Langdana, Founder of Wilderness Expedition Dentistry, shared a post on LinkedIn:
“Why does blast traumatised facial tissue keep swelling – and often heal badly – even after the bleeding has been controlled and the wound has been treated?
It is not simply the result of the mechanical injury itself.
One important part of the story is ROS/RNS-mediated damage to the endothelial glycocalyx.
The glycocalyx is the thin protective layer lining the inside of our blood vessels.
Normally, it helps maintain vascular integrity, limits albumin and fluid leakage, discourages leukocyte and platelet adhesion, and supports normal endothelial signalling.
Following severe trauma, increased reactive oxygen and nitrogen species (ROS/RNS) can activate enzymes that damage and shed this glycocalyx.
The consequences can be significant:
- Capillary leak – albumin and fluid escape into tissues – oedema – loss of the anti-adhesive surface – leukocyte and platelet adhesion – inflammation.
- Microvascular thrombosis and coagulopathy – impaired tissue perfusion
- Reduced endothelial Nitric Oxide (NO) ( signalling – abnormal vasoreactivity
- Poorer oxygen delivery to already injured tissues.
The result is a vicious cycle:
Trauma – ROS/RNS – glycocalyx damage – capillary leak and inflammation and microcirculatory dysfunction – tissue hypoxia – oedema and impaired healing.
This is particularly relevant when we try to understand why severely traumatised tissues can continue to swell, become hypoxic and heal poorly even after the initial surgical problem has been addressed.
The endothelial glycocalyx is microscopic – but its loss can have macroscopic consequences.”

Stay updated with Hemostasis Today.
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk
-
Sep 4, 2026, 04:56Marwa Mostafa: Microcytosis Is Not Always Iron Deficiency
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community